What a relief from holiday aches

Curry, Sheree R.
April 2000
Advertising Age;4/3/2000, Vol. 71 Issue 14, pS12
Trade Publication
Describes the Internet advertising campaign created by GCI Healthcare for Glaxo Wellcome's migraine reliever Imitrex.


Related Articles

  • Glaxo recruits patients against formularies. Dickinson, James G. // Medical Marketing & Media;Feb99, Vol. 34 Issue 2, p36 

    Reports on Glaxo Wellcome PLC's launching of a direct-to-mail promotion aimed at enlisting patient support against managed care formularies that discriminate against its bronchodilator Severent.

  • Grey wins two Glaxo brands.  // Medical Marketing & Media;Jan2000, Vol. 35 Issue 1, p22 

    Reports on the contract awarded by Glaxo Wellcome PLC to Grey Advertising Inc. for direct-to-consumer advertising of the smoking cessation product Zyban and the anti-depressant Wellburrin. Annual billing for the two accounts; Glaxo's previous award to Grey.

  • McCanns lands ...40m Glaxo Wellcome work. Cozens, Claire // Campaign;01/08/99, Issue 1, p4 

    Reports that Glaxo Wellcome has appointed McCann-Erickson to handle advertising of its over-the-counter brands outside the United States. Total worth of the advertising account; Other agencies considered for the account; Terms of the account agreement.

  • Glaxo Wellcome job cuts.  // Chemical Week;9/13/1995, Vol. 157 Issue 9, p8 

    Reports that Glaxo Wellcome will shed 7,500 jobs worldwide or more than 11% of its staff following Glaxo's acquisition of Wellcome. Cost of integration.

  • Pharmacists prefer Glaxo.  // Drug Topics;2/19/96, Vol. 140 Issue 4, p8 

    Focuses on the ranking of Glaxo Wellcome in Scott-Levin's survey on popular sales representatives of drug manufacturers.

  • Glaxo Wellcome Implements Direct-Purchase Plan.  // DRIP Investor;Jun2000, Vol. 9 Issue 6, p2 

    Reports the implementation of direct-purchase plan by Glaxo Wellcome Pharmaceutical Company in Great Britain. Minimum initial investment in the Yahoo plan; Availability of the automatic monthly investment services; Expansion plan of Glaxo Wellcome.

  • FDA approves use of antiseizure medication to control epilepsy.  // Hudson Valley Business Journal;02/01/99-02/08/99, Vol. 9 Issue 20, p14 

    Reports on the United States Food & Drug Administration's approval of Glaxo Wellcome PLC's antiseizure drug Lamictal for an expanded use in the treatment of epilepsy. Previous availability of the drug.

  • Review is tough to stomach.  // Adweek Eastern Edition;4/28/1997, Vol. 38 Issue 17, p3 

    Reports on Glaxo Wellcome PLC's `overdetailed' questionnaire presented to advertising agencies participating in the review of Glaxo's consolidated media planning and buying account.

  • Glaxo Wellcome to increase sales force. Ryan, Frances // Caribbean Business;5/1/1997, Vol. 25 Issue 17, p13 

    Reports on the increases of Glaxo Wellcome's distribution and service operations' sales force in Puerto Rico. Profitability of the company from the island's prescription drug market; Investments for research and development; Company's short-term objectives; Popularity of the company's GG167...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics